Full 2L QBank
Pharmacology Osteoporosis, Sex Hormones and OCPs dc275cc3

Which of the following statements about romosozumab is FALSE?

A
It is a monoclonal antibody against RANK ligand
B
It acts by inhibiting osteoclast
C
It acts by stimulating osteoblast
D
It is indicated in post menopausal osteoporosis
High-Yield Explanation
Romosozumab is a monoclonal antibody against sclerostin. Denosumab is monoclonal antibody against RANK ligand. Romosozumab has dual action in osteoporosis. It stimulates osteoblast as well as inhibits osteoclast. It is used for treatment of post menopausal osteoporosis.
← Previous Question Next Question →

Related Pharmacology MCQs

Which of the following is glucocoicoid synthesis inhibitor?
General
At a high altitude of 3000 m, a person complains of breathlessness. All of the following can...
General
All of the following drugs act on cell membrane except:
General
A non-competitive inhibitor of an enzyme?
General
Which of the following is a phase I metabolic reaction?
General
Explore All Pharmacology Questions →

Practice 2,00,000+ NEET PG Questions Free

Timed mock tests, mistake queue analytics, audio lectures & zero attempt limits on i❤️Exams.

Start Free Mock Test Now